Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26037662 | 0.98 | CASP2 (0.58) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL7897141 | 0.95 | CASP2 (0.62) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL30890794 | 0.93 | DNM1 (0.56) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL14880032 | 0.89 | NAAA (0.61) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL6866377 | 0.88 | DNM1 (0.50) | CASP2DNM1NAAAFAAHKDM4A | |
| SCHEMBL6860236 | 0.88 | DNM1 (0.50) | CASP2DNM1NAAAFAAHKDM4A | |
| SCHEMBL27347939 | 0.87 | DNM1 (0.64) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL1258600 | 0.87 | DNM1 (0.50) | CASP2DNM1NAAAFAAHEPHX1 | |
| SCHEMBL15397314 | 0.87 | FAAH (0.61) | CASP2DNM1NAAAFAAHKDM4A | |
| SCHEMBL16900384 | 0.86 | CNR1 (0.68) | CNR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12343411-B2 | Compositions and methods for treating keratinous substrates | L'OREAL (FR) | 2025-07-01 | — | — | US | disclosed |
| WO-2020242787-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATINOUS SUBSTRATES | LI DONGCUI (US) | 2020-12-03 | — | — | WO | disclosed |
| US-20200375854-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATINOUS SUBSTRATES | L'OREAL (FR) | 2020-12-03 | — | — | US | disclosed |
| EP-1718269-B1 | MAKE-UP COMPOSITION | PROCTER & GAMBLE (US) | 2014-12-17 | — | — | EP | disclosed |
| US-8597622-B2 | Deodorant cosmetic composition comprising a combination of a lipophilic salicylic acid derivative and an antiperspirant aluminium salt | L'OREAL (FR) | 2013-12-03 | — | — | US | disclosed |
| US-8563754-B2 | Compounds, compositions and methods for preventing skin darkening | NEW YORK UNIVERSITY (US) | 2013-10-22 | — | — | US | disclosed |
| WO-2012072409-A2 | PROCESS FOR TREATING BODY ODOUR COMBINING A TOPICAL DEODORANT PRODUCT WITH AN ORAL PERFUME; DEODORIZING KIT | L'OREAL (FR) | 2012-06-07 | — | — | WO | disclosed |
| EP-1791603-B1 | COSMETIC COMPOSITION COMPRISING AS ANTIPERSPIRANT AGENT A FLOCCULATING WATER-SOLUBLE POLYMER; PROCESS FOR TREATING PERSPIRATION | OREAL (FR) | 2012-05-09 | — | — | EP | disclosed |
| EP-1011629-B1 | CLEANSING AND CONDITIONING PRODUCTS FOR SKIN OR HAIR WITH IMPROVED DEPOSITION OF CONDITIONING INGREDIENTS | PROCTER & GAMBLE (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-1416905-B1 | Sunscreen composition | PROCTER & GAMBLE (US) | 2012-02-15 | — | — | EP | disclosed |
| US-5840287-A | AMIDE COMPOUND WITH GELLING AGENT AND ACTIVE MATERIAL | PROCTER & GAMBLE COMPANY (US) | 1998-11-24 | — | — | US | disclosed |
| WO-1998027951-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS SUBSTANTIALLY FREE OF SELECT POLAR SOLVENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027950-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027949-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027955-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027952-A1 | METHODS OF MAKING LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027939-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027954-A1 | ANTIPERSPIRANT COMPOSITIONS CONTAINING GELLANTS IN THE FORM OF ALKYL AMIDES OF DI- AND TRI-CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| US-5744130-A | COMPRISING ACTIVE MATERIAL, NONPOLYMERIC GELLANT, ANHYDROUS LIQUID CARRIER; LOW RESIDUE | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| WO-1998016196-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE PERFORMANCE OF LONG-WEARING COSMETIC PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12343411-B2 | Compositions and methods for treating keratinous substrates | KRT18, GK, LIPA | CASP2 3094/4885DNM1 2707/4885NAAA 2261/4885 |
| US-20200375854-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATINOUS SUBSTRATES | KRT18, GK, LIPA | CASP2 3094/4885DNM1 2707/4885NAAA 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.